The effect of ketoprofen creams on periodontal disease in rhesus monkeys
| Autor: | M. C. Alfano, Richard I. Vogel, Marjorie K. Jeffcoat, J. G. Collins, Steven Offenbacher, K. L. Li, M. A. Smith |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
Male
Ketoprofen Molar medicine.medical_specialty Administration Topical medicine.medical_treatment Bleeding on probing Alveolar Bone Loss Dental Plaque Dentistry Leukotriene B4 Gastroenterology Dinoprostone Placebos Random Allocation Double-Blind Method Internal medicine Edema Periodontal Attachment Loss medicine Animals Vitamin E Periodontitis Ligature Dental alveolus Emollients Tumor Necrosis Factor-alpha business.industry Anti-Inflammatory Agents Non-Steroidal Gingival Crevicular Fluid medicine.disease Gingivitis Macaca mulatta Radiographic Image Enhancement Thromboxane B2 Subtraction Technique Periodontics Female medicine.symptom Gingival Hemorrhage business Follow-Up Studies Interleukin-1 medicine.drug |
| Zdroj: | Journal of Periodontal Research. 31:525-532 |
| ISSN: | 1600-0765 0022-3484 |
| DOI: | 10.1111/j.1600-0765.1996.tb00516.x |
| Popis: | Ketoprofen creams were evaluated for the treatment of periodontal disease in a placebo-controlled, double-blind study in the rhesus monkeys, Macaca mulatta. Two formulations containing ketoprofen (1%), with or without vitamin E, were evaluated against appropriate controls (8 monkeys per group). Two weeks prior to treatment, the animals received prophylaxis on only the left side of the mouth (spontaneous model). Selected teeth on the right side of the mouth were ligated (ligature model). The creams were administered to the gingiva once daily at a standard dose of 1.8 ml per monkey for 6 months. Clinical assessments were made 2 wk before initiation, at baseline and 1, 2, 3 and 6 months post-treatment. The clinical parameters included plaque formation, gingival redness, edema, bleeding on probing and Ramfjord Attachment Level measurements (RAL). Radiographs were taken at 2 wk before initiation, baseline and at 3 and 6 months post-treatment. Digital, subtraction radiography was used to measure vertical linear bone loss along the interproximal root surfaces of the left and right mandibular first molars. Gingival crevicular fluid (GCF) was collected for biochemical assays on PGE2, TxB2, LTB4, IL-1 beta and TNF alpha. There were no significant differences among groups with respect to gingival indices. Radiographic data demonstrated significant positive effects on bone activity in both groups treated with ketoprofen formulations with improvement over time in the ligature model (0.01 < or = p < or = 0.04). The placebo group exhibited bone loss of 1.96 +/- 0.48 and 1.40 +/- 0.56 mm per site at 3 and 6 months, respectively. The group treated with ketoprofen cream showed an apparent bone gain of 0.28 +/- 0.41 and 0.78 +/- 0.47 mm per site at 3 and 6 months, respectively. The group treated with ketoprofen cream containing vitamin E showed a mean bone loss of 0.41-0.48 mm per site at 3 months with improvement to an apparent bone gain of 0.31 +/- 0.44 mm per site at 6 months. The biochemical data demonstrated early and significant suppression of GCF-LTB4 by both ketoprofen formulations at 1 month, which preceded the significant suppression of GCF-PGE2 at 2 and 3 months in the ligature model (p < 0.003) and at 2 to 6 months in the spontaneous model (p < 0.02). We conclude that ketoprofen at 1% level in suitable topical vehicles can effectively inhibit GCF-LTB4 and GCF-PGE2 and positively alter alveolar bone activity in the ligature-induced model of periodontitis in the monkey. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text